Table 2.
Impact of double expression of MYC and BCL2 on outcome in DLBCL
PFS indicates progression-free survival; and HR, hazard ratio.
*Results from the training cohort remained significant in the validation cohort.
Impact of double expression of MYC and BCL2 on outcome in DLBCL
PFS indicates progression-free survival; and HR, hazard ratio.
*Results from the training cohort remained significant in the validation cohort.